4//SEC Filing
Lonczak David Lawrence 4
Accession 0001181431-09-046994
CIK 0001086467other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:28 PM ET
Size
7.4 KB
Accession
0001181431-09-046994
Insider Transaction Report
Form 4
Lonczak David Lawrence
VP, Chief Marketing Officer
Transactions
- Award
Common Stock
2009-10-02+16,744→ 160,864 total - Award
Stock-Settled Stock Appreciation Rights
2009-10-02+143,519→ 143,519 totalExercise: $2.28From: 2009-10-02Exp: 2019-10-02→ Common Stock (143,519 underlying)
Footnotes (2)
- [F1]2008 Equity Incentive Plan restricted stock award.
- [F2]Indicates vesting commencement date; the stock-settled stock appreciation rights ("SSARs") become exercisable as to the SSARs'original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter.
Documents
Issuer
DRUGSTORE COM INC
CIK 0001086467
Entity typeother
Related Parties
1- filerCIK 0001384516
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:28 PM ET
- Size
- 7.4 KB